JP2016502406A - 神経変性疾患の診断及び／又は予知の方法 - Google Patents

神経変性疾患の診断及び／又は予知の方法 Download PDF

Info

Publication number
JP2016502406A
JP2016502406A JP2015543486A JP2015543486A JP2016502406A JP 2016502406 A JP2016502406 A JP 2016502406A JP 2015543486 A JP2015543486 A JP 2015543486A JP 2015543486 A JP2015543486 A JP 2015543486A JP 2016502406 A JP2016502406 A JP 2016502406A
Authority
JP
Japan
Prior art keywords
mitochondrial dna
seq
disease
alzheimer
csf
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2015543486A
Other languages
English (en)
Japanese (ja)
Other versions
JP2016502406A5 (enExample
Inventor
オリバ，ラモン トルリャス
オリバ，ラモン トルリャス
シルバ，ホアナ フィゲイロ
シルバ，ホアナ フィゲイロ
ポドレスニイ，ペタル ミアイロビチ
ポドレスニイ，ペタル ミアイロビチ
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Centro de Investigacion Biomedica en Red de Enfermedades Neurodegenerativas CIBERNED
Original Assignee
Centro de Investigacion Biomedica en Red de Enfermedades Neurodegenerativas CIBERNED
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Centro de Investigacion Biomedica en Red de Enfermedades Neurodegenerativas CIBERNED filed Critical Centro de Investigacion Biomedica en Red de Enfermedades Neurodegenerativas CIBERNED
Publication of JP2016502406A publication Critical patent/JP2016502406A/ja
Publication of JP2016502406A5 publication Critical patent/JP2016502406A5/ja
Pending legal-status Critical Current

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/118—Prognosis of disease development
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/156—Polymorphic or mutational markers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Analytical Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
JP2015543486A 2012-11-22 2013-10-17 神経変性疾患の診断及び／又は予知の方法 Pending JP2016502406A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
ESP201231807 2012-11-22
ES201231807A ES2482866B1 (es) 2012-11-22 2012-11-22 Método de diagnóstico y/o pronóstico de enfermedades neurodegenerativas.
PCT/ES2013/070713 WO2014080054A1 (es) 2012-11-22 2013-10-17 Método de diagnóstico y/o pronóstico de enfermedades neurodegenerativas

Publications (2)

Publication Number Publication Date
JP2016502406A true JP2016502406A (ja) 2016-01-28
JP2016502406A5 JP2016502406A5 (enExample) 2016-12-01

Family

ID=50775580

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2015543486A Pending JP2016502406A (ja) 2012-11-22 2013-10-17 神経変性疾患の診断及び／又は予知の方法

Country Status (5)

Country Link
US (1) US20150361495A1 (enExample)
EP (1) EP2924124A4 (enExample)
JP (1) JP2016502406A (enExample)
ES (1) ES2482866B1 (enExample)
WO (1) WO2014080054A1 (enExample)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPWO2017170572A1 (ja) * 2016-03-28 2019-02-07 国立大学法人大阪大学 ストレスバイオマーカー

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3181701A1 (en) * 2015-12-17 2017-06-21 Consejo Superior De Investigaciones Cientificas Method for the sub-classification of patients suffering from parkinson disease
JP6654326B2 (ja) * 2016-03-28 2020-02-26 国立大学法人大阪大学 眼科疾患のバイオマーカー
FR3144164A1 (fr) 2022-12-23 2024-06-28 Neolys Diagnostics Détermination du statut d’un individu vis-à-vis de la maladie d’Alzheimer

Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1994009162A1 (en) * 1992-10-20 1994-04-28 Emory University School Of Medicine Detection of mitochondrial dna mutations associated with alzheimer's disease and parkinson's disease
JPH1099085A (ja) * 1996-05-16 1998-04-21 Affymetrix Inc ヒトミトコンドリアｄｎａの多形性
JP2002518023A (ja) * 1998-06-15 2002-06-25 マイトコー ミトコンドリア外ｄｎａの定量に基く診断方法
JP2003521879A (ja) * 1999-04-20 2003-07-22 マイトコー アルツハイマー病とともに分離するミトコンドリア遺伝子における一塩基多型
JP2004532043A (ja) * 2001-05-29 2004-10-21 ザ ユニバーシティ オブ ブリティッシュ コロンビア ミトコンドリアｄｎａアッセイの薬理学的応用
JP2005525124A (ja) * 2002-05-14 2005-08-25 ザ チャイニーズ ユニバーシティ オブ ホンコン 核酸の検出及び分画により病態を評価する方法
JP2008500058A (ja) * 2004-03-29 2008-01-10 ザ、リージェンツ、オブ、ザ、ユニバーシティ、オブ、カリフォルニア アルツハイマー病および他の神経変性疾患の発症前または発症後診断の方法および組成物

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6218117B1 (en) * 1998-06-15 2001-04-17 Mitokor Compositions and methods for identifying agents that quantitatively alter detectable extramitochondrial DNA:mitochondrial DNA ratios
JP5537804B2 (ja) * 2005-04-18 2014-07-02 ミトミクス インコーポレーテッド 日光曝露、前立腺癌および他の癌の検出用の診断ツールとしての、ミトコンドリアの突然変異および再配置
WO2008117027A2 (en) * 2007-03-23 2008-10-02 King's College London Altered mitochondrial activity in diseases resulting from oxidative stress
US9050275B2 (en) * 2009-08-03 2015-06-09 Theta Biomedical Consulting & Development Co., Inc. Methods of screening for and treating autism spectrum disorders and compositions for same
WO2011066476A1 (en) * 2009-11-25 2011-06-03 Quantalife, Inc. Methods and compositions for detecting genetic material
JP5831919B2 (ja) * 2011-02-21 2015-12-09 国立大学法人北海道大学 神経変性疾患の検査方法

Patent Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1994009162A1 (en) * 1992-10-20 1994-04-28 Emory University School Of Medicine Detection of mitochondrial dna mutations associated with alzheimer's disease and parkinson's disease
JPH1099085A (ja) * 1996-05-16 1998-04-21 Affymetrix Inc ヒトミトコンドリアｄｎａの多形性
JP2002518023A (ja) * 1998-06-15 2002-06-25 マイトコー ミトコンドリア外ｄｎａの定量に基く診断方法
JP2003521879A (ja) * 1999-04-20 2003-07-22 マイトコー アルツハイマー病とともに分離するミトコンドリア遺伝子における一塩基多型
JP2004532043A (ja) * 2001-05-29 2004-10-21 ザ ユニバーシティ オブ ブリティッシュ コロンビア ミトコンドリアｄｎａアッセイの薬理学的応用
JP2005525124A (ja) * 2002-05-14 2005-08-25 ザ チャイニーズ ユニバーシティ オブ ホンコン 核酸の検出及び分画により病態を評価する方法
JP2008500058A (ja) * 2004-03-29 2008-01-10 ザ、リージェンツ、オブ、ザ、ユニバーシティ、オブ、カリフォルニア アルツハイマー病および他の神経変性疾患の発症前または発症後診断の方法および組成物

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
ANAL. CHEM. (2011) VOL.83, PP.8604-8610, JPN6017034887, ISSN: 0003793440 *
BIOCHIM. BIOPHYS. ACTA. (2012) VOL.1820, NO.5, PP.553-564, JPN6017034889, ISSN: 0003640170 *

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPWO2017170572A1 (ja) * 2016-03-28 2019-02-07 国立大学法人大阪大学 ストレスバイオマーカー

Also Published As

Publication number Publication date
US20150361495A1 (en) 2015-12-17
ES2482866A1 (es) 2014-08-04
ES2482866B1 (es) 2015-05-12
WO2014080054A1 (es) 2014-05-30
EP2924124A1 (en) 2015-09-30
EP2924124A4 (en) 2016-08-31

Similar Documents

Publication Publication Date Title
Steenweg et al. An overview of L‐2‐hydroxyglutarate dehydrogenase gene (L2HGDH) variants: a genotype–phenotype study
Podlesniy et al. Low cerebrospinal fluid concentration of mitochondrial DNA in preclinical Alzheimer disease
Camargos et al. Familial Parkinsonism and early onset Parkinson's disease in a Brazilian movement disorders clinic: phenotypic characterization and frequency of SNCA, PRKN, PINK1, and LRRK2 mutations
Freeze et al. Regional expression of genes mediating trans-synaptic alpha-synuclein transfer predicts regional atrophy in Parkinson disease
Kukshal et al. Association study of neuregulin-1 gene polymorphisms in a North Indian schizophrenia sample
KR20140044375A (ko) 알츠하이머병을 나타내는 마이크로rna 바이오마커들
EP3294903B1 (en) Method for in vitro diagnosis of dementia with lewy bodies using alphasynuclein gene transcripts
JP2013520185A (ja) レビー小体認知症診断の遺伝子マーカー
JP2016502406A (ja) 神経変性疾患の診断及び／又は予知の方法
JP5216982B2 (ja) 禁煙支援治療に有用な遺伝子多型
Clot et al. Partial deletions of the GRN gene are a cause of frontotemporal lobar degeneration
JP6695142B2 (ja) 抗精神病薬に基づく処置により誘導される錐体外路症状（ｅｐｓ）の発症を予測する方法
CN114703278A (zh) 一种肌萎缩侧索硬化致病基因、检测试剂盒及引物组
Venturelli et al. The NOS3 G894T (Glu298Asp) polymorphism is a risk factor for frontotemporal lobar degeneration
Li et al. A novel ATRX mutation causes Smith-Fineman-Myers syndrome in a Chinese family
JP5879665B2 (ja) ＰＤＥ８Ａ ｍＲＮＡ前駆体の編集プロファイリング：治療効力および／もしくは有効性または潜在的薬物副作用を診断するため、ならびに予測および評価するための、ヒト組織における特異的バイオマーカーとしてのＡＤＡＲｓ活性の使用
US20160186263A1 (en) Using plexin-a4 as a biomarker and therapeutic target for alzheimer's disease
US10260098B2 (en) FIG4 gene mutations in neurodegeneration
JP5643933B2 (ja) Ｚｎｆ５１２ｂ遺伝子の一塩基多型に基づく筋萎縮性側索硬化症の検査方法
EP4058602A1 (en) Oligonucleotide primers for the characterization of the cag tract and measurement of mutant mrna in the context of polyglutamine disorders
JP7731540B2 (ja) アミロイドβ蓄積リスクの有無の指標とする方法、一塩基多型（ＳＮＰ）の存在又は非存在を検出する方法、組成物、及びキット
JP2014521327A (ja) レビー小体型認知症の診断のための遺伝子マーカー
US20060057624A1 (en) Alternatively spliced pre-mRNA transcripts in neurodegenerative disease
JP2008500058A (ja) アルツハイマー病および他の神経変性疾患の発症前または発症後診断の方法および組成物
KR102735656B1 (ko) Krt32 유전자의 dna 메틸화 변화를 이용한 알츠하이머병 치매 예측진단 마커

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20161014

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20161014

A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20170830

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20170912

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20180515